Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: Results from the SAFER trial

Journal of the American College of Cardiology

Volumn 44, Issue 9, 2004, Pages 1801-1808

  Cohen, David J ^a,b   Murphy, Sabina A ^a   Baim, Donald S ^c   Lavelle, Tara A ^a   Berezin, Ronna H ^a   Cutlip, Donald E ^a,b   Ho, Kalon K L ^a,b   Kuntz, Richard E ^a,c  

^a HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BALLOON OCCLUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; EMBOLISM; EMBOLISM PREVENTION; FEMALE; HOSPITAL BILLING; HOSPITALIZATION; HUMAN; ISCHEMIA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SAPHENOUS VEIN GRAFT; SURVIVAL;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; CORONARY RESTENOSIS; COST-BENEFIT ANALYSIS; EMBOLISM; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT ADMISSION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; QUALITY-ADJUSTED LIFE YEARS; SAPHENOUS VEIN; TREATMENT OUTCOME;

EID: 7044245803     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.05.086     Document Type: Article

References (26)

1. M.K. Hong, R. Mehran, G Dangas Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality Circulation 100 1999 2400 2405
2. P.J. de Feyter, P. Serruys, M van den Brand Percutaneous transluminal angioplasty of a totally occluded venous bypass graft: a challenge that should be resisted Am J Cardiol 64 1989 88 90
3. W.S. Weintraub, E.L. Jones, D.C Morris Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery Circulation 95 1997 868 877
4. D.R. Holmes, E.J. Topol, R.M Califf A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions Circulation 91 1995 1966 1974
5. M. Dooris, M. Hoffmann, S Glazier Comparative results of transluminal extraction coronary atherectomy in saphenous vein graft lesions with and without thrombus J Am Coll Cardiol 25 1995 1700 1705
6. R.E. Kuntz, D.S. Baim, D.J Cohen A randomized prospective multicenter trial comparing vacuum thrombectomy to intracoronary urokinase for coronary and vein graft thrombus: results of the Vein Graft Angiojet study (VeGAS 2) Am J Cardiol 89 2002 326 330
7. M.P. Savage, J.S. Douglas, D.L Fischman Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts N Engl J Med 337 1997 740 747
8. M. Roffi, D. Mukherjee, D.P Chew Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials Circulation 106 2002 3063 3067
9. D.S. Baim, D. Wahr, B George Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts Circulation 105 2002 1285 1290
10. D.J. Cohen, S. Ramee, D.S Baim Economic assessment of rheolytic thrombectomy vs. intracoronary urokinase for treatment of extensive intracoronary thrombus: results from a randomized clinical trial Am Heart J 142 2001 648 656
11. P. Doubilet, M.C. Weinstein, B.J. McNeil Use and misuse of the term "cost effective" in medicine N Engl J Med 314 1986 253 256
12. D.J. Cohen, H.M. Krumholz, C.A Sukin In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty: results from a randomized clinical trial Circulation 92 1995 2480 2487
13. M. Shwartz, D.W. Young, R. Siegrist The ratio of costs to charges: how good a basis for estimating hospital costs Inquiry 32 1995 476 481
14. D.A. Taira, T.B. Seto, R Siegrist Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials Am Heart J 145 2003 452 458
15. B. Efron, R.J. Tibshirani An Introduction to the Bootstrap 1993 Chapman & Hall New York, NY
16. D.B. Mark, M.A. Hlatky, R.M Califf Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction N Engl J Med 332 1995 1418 1424
17. E.M. Mahoney, C.T. Jurkovitz, H Chu Cost and cost-effectiveness of an early invasive vs. conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction JAMA 288 2002 1851 1858
18. M.R. Reynolds, N. Neil, K.K.L Ho Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center U.S. experience Am Heart J 145 2003 334 342
19. M. Johannesson, B. Jonsson, J Kjekshus Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease N Engl J Med 336 1997 332 336
20. M.C. Weinstein, W.B. Stason Cost-effectiveness of coronary artery bypass surgery Circulation 66 1982 III56 66
21. W.C. Winkelmayer, M.C. Weinstein, M.A Mittleman Health economic evaluations: the special case of end-stage renal disease treatment Med Decis Making 22 2002 417 430
22. R.M. Califf, A.E. Abdelmeguid, R.E Kuntz Myonecrosis after revascularization procedures J Am Coll Cardiol 31 1998 241 251
23. A.E. Abdelmeguid, E.J. Topol, P.L. Whitlow, S.K. Sapp, S.G. Ellis Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions Circulation 94 1996 528 536
24. D. Mark, R. Harrington, A Lincoff Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes Circulation 101 1999 366 371
25. H.M. Krumholz, R.C. Pasternak, M.C Weinstein Cost-effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspsected acute myocardial infarction N Engl J Med 327 1992 7 13
26. W.S. Weintraub, T.D. Thompson, S Culler Targeting patients undergoing angioplasty for thrombus inhibition: a cost-effectiveness and decision support model Circulation 102 2000 392 398